FHTX
Price
$4.25
Change
+$0.10 (+2.40%)
Updated
May 2, 02:31 PM (EDT)
Capitalization
231.35M
10 days until earnings call
GBIO
Price
$0.44
Change
-$0.00 (-0.00%)
Updated
May 2, 02:42 PM (EDT)
Capitalization
29.49M
96 days until earnings call
Ad is loading...

FHTX vs GBIO

Header iconFHTX vs GBIO Comparison
Open Charts FHTX vs GBIOBanner chart's image
Foghorn Therapeutics
Price$4.25
Change+$0.10 (+2.40%)
Volume$100
Capitalization231.35M
Generation Bio
Price$0.44
Change-$0.00 (-0.00%)
Volume$200
Capitalization29.49M
FHTX vs GBIO Comparison Chart
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FHTX vs. GBIO commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Hold and GBIO is a Buy.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (FHTX: $4.16 vs. GBIO: $0.44)
Brand notoriety: FHTX and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 56% vs. GBIO: 60%
Market capitalization -- FHTX: $231.35M vs. GBIO: $29.49M
FHTX [@Biotechnology] is valued at $231.35M. GBIO’s [@Biotechnology] market capitalization is $29.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, both FHTX and GBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 5 TA indicator(s) are bullish while GBIO’s TA Score has 4 bullish TA indicator(s).

  • FHTX’s TA Score: 5 bullish, 5 bearish.
  • GBIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both FHTX and GBIO are a good buy in the short-term.

Price Growth

FHTX (@Biotechnology) experienced а -6.94% price change this week, while GBIO (@Biotechnology) price change was +4.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +8.33%, and the average quarterly price growth was -5.51%.

Reported Earning Dates

FHTX is expected to report earnings on Aug 12, 2025.

GBIO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($231M) has a higher market cap than GBIO($29.5M). FHTX YTD gains are higher at: -11.864 vs. GBIO (-58.491). GBIO has higher annual earnings (EBITDA): -74.26M vs. FHTX (-97.17M). FHTX has more cash in the bank: 244M vs. GBIO (185M). FHTX has less debt than GBIO: FHTX (37.1M) vs GBIO (93.6M). FHTX has higher revenues than GBIO: FHTX (22.6M) vs GBIO (19.9M).
FHTXGBIOFHTX / GBIO
Capitalization231M29.5M783%
EBITDA-97.17M-74.26M131%
Gain YTD-11.864-58.49120%
P/E RatioN/AN/A-
Revenue22.6M19.9M114%
Total Cash244M185M132%
Total Debt37.1M93.6M40%
TECHNICAL ANALYSIS
Technical Analysis
FHTXGBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPS15.220.55
+3.75%
Cooper-Standard Automotive
ACHR8.480.15
+1.80%
Archer Aviation
LVS36.810.14
+0.38%
Las Vegas Sands Corp
PRDO25.170.05
+0.20%
Perdoceo Education Corp
DUOT6.69-0.26
-3.81%
Duos Technologies Group

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with NAUT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-0.95%
NAUT - FHTX
52%
Loosely correlated
-0.54%
XNCR - FHTX
50%
Loosely correlated
-1.45%
ABOS - FHTX
49%
Loosely correlated
-5.31%
IMNM - FHTX
48%
Loosely correlated
+0.80%
GBIO - FHTX
46%
Loosely correlated
+1.59%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ATOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+1.59%
ATOS - GBIO
48%
Loosely correlated
-6.11%
ABOS - GBIO
47%
Loosely correlated
-5.31%
AURA - GBIO
47%
Loosely correlated
+4.12%
ATNM - GBIO
46%
Loosely correlated
-1.97%
FHTX - GBIO
45%
Loosely correlated
-0.95%
More